デフォルト表紙
市場調査レポート
商品コード
1221043

スマート吸入器の世界市場:市場を牽引する喘息とCOPDの有病率の上昇

Rising Prevalence Rates of Asthma and COPD will drive the Global Market for Smart Inhalers over the Forecast Duration

出版日: | 発行: Persistence Market Research | ページ情報: 英文 193 Pages | 納期: 2~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
スマート吸入器の世界市場:市場を牽引する喘息とCOPDの有病率の上昇
出版日: 2022年12月29日
発行: Persistence Market Research
ページ情報: 英文 193 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のスマート吸入器市場について調査し、市場力学、セグメント別および地域別の動向、および企業プロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要動向
  • イノベーション/開発動向

第4章 主要な成功要因

  • 技術的進歩の規制シナリオ
  • 主要なプロモーション戦略:メーカー別
  • 疾患疫学:COPDと喘息
  • 新製品の承認
  • PESTEL分析
  • ポーターの分析
  • バリューチェーン分析

第5章 市場の背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19危機分析

  • 市場シナリオ(2022年)
  • COVID-19と影響分析
    • 製品別
    • 疾患適応別
    • 流通チャネル別
    • 地域別

第7章 世界のスマート吸入器市場の需要分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第8章 世界のスマート吸入器市場:価格分析

  • 地域の価格分析: 製品別
  • 価格の内訳
    • メーカーレベルの価格
    • ディストリビューターレベルの価格
  • 世界の平均価格分析ベンチマーク
  • 価格設定の前提条件

第9章 世界のスマート吸入器市場の需要分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第10章 世界のスマート吸入器市場の分析と予測:製品別

  • イントロダクション/主要な調査結果
  • 過去の市場と分析:製品別
  • 現在および将来の市場と分析・予測: 製品別
    • ドライパウダー吸入器(DPI)ベース
    • 定量噴霧式吸入器(MDI)ベース
  • 市場魅力度分析:製品別

第11章 世界のスマート吸入器市場の分析と予測:疾患適応別

  • イントロダクション/主要な調査結果
  • 過去の市場分析技術
  • 現在および将来の市場分析と予測:疾患適応別
    • 喘息
    • COPD
  • 市場魅力度分析:エンドユーザー別

第12章 世界のスマート吸入器市場の分析と予測:流通チャネル別

  • イントロダクション/主要な調査結果
  • 過去の市場分析用途
  • 現在および将来の市場分析と予測: 流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場魅力度分析:流通チャネル別

第13章 世界のスマート吸入器市場の分析と予測:地域別

  • イントロダクション
  • 過去の市場と分析:地域別
  • 現在および将来の市場と分析・予測: 地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力度分析:地域別

第14章 北米のスマート吸入器市場の分析と予測

第15章 ラテンアメリカのスマート吸入器市場の分析と予測

第16章 欧州のスマート吸入器市場の分析と予測

第17章 南アジアのスマート吸入器市場の分析と予測

第18章 東アジアのスマート吸入器市場の分析と予測

第19章 オセアニアのスマート吸入器市場の分析と予測

第20章 中東・アフリカのスマート吸入器市場の分析と予測

第21章 市場構造分析

  • 市場分析:企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • OPKO Health, Inc
    • AstraZeneca plc
    • GlaxoSmithKline Plc.
    • Propeller Health
    • Aptar Pharma
    • Adherium Limited
    • Novartis AG
    • Boehringer Ingelheim
    • Teva Pharmaceutical Industries Ltd
    • H&T Presspart Manufacturing Ltd.
    • Sensirion AG
    • Cohero Health, Inc.
    • RYAH Medtech Inc.

第23章 前提条件と使用している頭字語

第24章 調査手法

図表

List of Tables

  • Table 01: Global Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 02: Global Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 03: Global Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 04: Global Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 05: Global Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Region
  • Table 06: North America Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 07: North America Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 08: North America Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 09: North America Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 10: North America Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 11: Latin America Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 12: Latin America Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 13: Latin America Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 14: Latin America Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 15: Latin America Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 16: Europe Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 17: Europe Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 18: Europe Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 19: Europe Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 20: Europe Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 21: South Asia Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 22: South Asia Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 23: South Asia Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 24: South Asia Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 25: South Asia Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 26: East Asia Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 27: East Asia Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 28: East Asia Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 29: East Asia Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 30: East Asia Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 31: Oceania Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 32: Oceania Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 33: Oceania Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 34: Oceania Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 35: Oceania Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel
  • Table 36: MEA Smart Inhalers Market Value (US$ Mn) Analysis 2013-2022 and Forecast 2023-2033, by Country
  • Table 37: MEA Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Product
  • Table 38: MEA Smart Inhalers Market Volume (Units) Analysis and Forecast 2013-2032, by Product
  • Table 39: MEA Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Disease Indication
  • Table 40: MEA Smart Inhalers Market Value (US$ Mn) Analysis and Forecast 2013-2032, by Distribution Channel

List of Figures

  • Figure 01: Global Smart Inhalers Market Volume (Units), 2013 - 2022
  • Figure 02: Global Smart Inhalers Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2023-2033
  • Figure 03: Smart Inhalers Market, Pricing Analysis per unit (US$), in 2023
  • Figure 04: Smart Inhalers Market, Pricing Forecast per unit (US$), in 2033
  • Figure 05: Global Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 06: Global Smart Inhalers Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 07: Global Smart Inhalers Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 08: Global Smart Inhalers Market Value Share (%) Analysis 2023 and 2033, by Product
  • Figure 09: Global Smart Inhalers Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
  • Figure 10: Global Smart Inhalers Market Attractiveness Analysis 2023-2033, by Product
  • Figure 11: Global Smart Inhalers Market Value Share (%) Analysis 2023 and 2033, by Disease Indication
  • Figure 12: Global Smart Inhalers Market Y-o-Y Growth (%) Analysis 2022-2033, by Disease Indication
  • Figure 13: Global Smart Inhalers Market Attractiveness Analysis 2023-2033, by Disease Indication
  • Figure 14: Global Smart Inhalers Market Value Share (%) Analysis 2023 and 2033, by Distribution Channel
  • Figure 15: Global Smart Inhalers Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution Channel
  • Figure 16: Global Smart Inhalers Market Attractiveness Analysis 2023-2033, by Distribution Channel
  • Figure 17: Global Smart Inhalers Market Value Share (%) Analysis 2023 and 2033, by Region
  • Figure 18: Global Smart Inhalers Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 19: Global Smart Inhalers Market Attractiveness Analysis 2023-2033, by Region
  • Figure 20: North America Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 21: North America Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 22: North America Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 23: North America Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 24: North America Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 25: North America Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 26: North America Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 27: North America Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 28: North America Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 29: North America Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 30: U.S. Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 31: Global Vs. U.S. Growth Comparison
  • Figure 32: U.S. Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 33: U.S. Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 34: U.S. Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 35: Canada Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 36: Global Vs. Canada. Growth Comparison
  • Figure 37: Canada Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 38: Canada Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 39: Canada Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 40: Latin America Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 41: Latin America Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 42: Latin America Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 43: Latin America Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 44: Latin America Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 45: Latin America Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 46: Latin America Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 47: Latin America Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 48: Latin America Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 49: Latin America Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 50: Mexico Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 51: Global Vs Mexico Growth Comparison
  • Figure 52: Mexico Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 53: Mexico Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 54: Mexico Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 55: Brazil Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 56: Global Vs. Brazil. Growth Comparison
  • Figure 57: Brazil Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 58: Brazil Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 59: Brazil Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 60: Argentina Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 61: Global Vs Argentina Growth Comparison
  • Figure 62: Argentina Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 63: Argentina Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 64: Argentina Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 65: Europe Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 66: Europe Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 67: Europe Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 68: Europe Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 69: Europe Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 70: Europe Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 71: Europe Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 72: Europe Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 73: Europe Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 74: Europe Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 75: UK Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 76: Global Vs. UK Growth Comparison
  • Figure 77: UK Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 78: UK Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 79: UK Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 80: Germany Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 81: Global Vs. Germany Growth Comparison
  • Figure 82: Germany Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 83: Germany Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 84: Germany Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 85: Italy Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 86: Global Vs. Italy Growth Comparison
  • Figure 87: Italy Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 88: Italy Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 89: Italy Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 90: France Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 91: Global Vs France Growth Comparison
  • Figure 92: France Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 93: France Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 94: France Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 95: Spain Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 96: Global Vs Spain Growth Comparison
  • Figure 97: Spain Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 98: Spain Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 99: Spain Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 100: Russia Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 101: Global Vs Russia Growth Comparison
  • Figure 102: Russia Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 103: Russia Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 104: Russia Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 105: BENELUX Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 106: Global Vs BENELUX Growth Comparison
  • Figure 107: BENELUX Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 108: BENELUX Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 109: BENELUX Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 110: East Asia Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 111: East Asia Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 112: East Asia Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 113: East Asia Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 114: East Asia Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 115: East Asia Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 116: East Asia Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 117: East Asia Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 118: East Asia Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 119: East Asia Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 120: China Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 121: Global Vs. China Growth Comparison
  • Figure 122: China Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 123: China Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 124: China Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 125: Japan Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 126: Global Vs. Japan Growth Comparison
  • Figure 127: Japan Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 128: Japan Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 129: Japan Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 130: South Korea Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 131: Global Vs South Korea Growth Comparison
  • Figure 132: South Korea Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 133: South Korea Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 134: South Korea Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 135: South Asia Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 136: South Asia Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 137: South Asia Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 138: South Asia Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 139: South Asia Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 140: South Asia Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 141: South Asia Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 142: South Asia Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 143: South Asia Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 144: South Asia Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 145: India Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 146: Global Vs. India Growth Comparison
  • Figure 147: India Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 148: India Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 149: India Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 150: Indonesia Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 151: Global Vs. Indonesia Growth Comparison
  • Figure 152: Indonesia Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 153: Indonesia Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 154: Indonesia Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 155: Malaysia Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 156: Global Vs. Malaysia Growth Comparison
  • Figure 157: Malaysia Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 158: Malaysia Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 159: Malaysia Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 160: Thailand Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 161: Global Vs. Thailand Growth Comparison
  • Figure 162: Thailand Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 163: Thailand Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 164: Thailand Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 165: Oceania Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 166: Oceania Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 167: Oceania Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 168: Oceania Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 169: Oceania Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 170: Oceania Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 171: Oceania Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 172: Oceania Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 173: Oceania Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 174: Oceania Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 175: Australia Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 176: Global Vs. Australia Growth Comparison
  • Figure 177: Australia Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 178: Australia Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 179: Australia Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 180: New Zealand Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 181: Global Vs New Zealand Growth Comparison
  • Figure 182: New Zealand Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 183: New Zealand Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 184: New Zealand Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 185: Middle East & Africa Smart Inhalers Market Value (US$ Mn) Analysis, 2013-2022
  • Figure 186: Middle East & Africa Smart Inhalers Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 187: Middle East & Africa Smart Inhalers Market Value Share, by Product (2023 E)
  • Figure 188: Middle East & Africa Smart Inhalers Market Value Share, by Disease Indication (2023 E)
  • Figure 189: Middle East & Africa Smart Inhalers Market Value Share, by Distribution Channel (2023 E)
  • Figure 190: Middle East & Africa Smart Inhalers Market Value Share, by Country (2023 E)
  • Figure 191: Middle East & Africa Smart Inhalers Market Attractiveness Analysis by Product, 2023-2033
  • Figure 192: Middle East & Africa Smart Inhalers Market Attractiveness Analysis by Disease Indication, 2023-2033
  • Figure 193: Middle East & Africa Smart Inhalers Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 194: Middle East & Africa Smart Inhalers Market Attractiveness Analysis by Country, 2023-2033
  • Figure 195: GCC Countries Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 196: Global Vs GCC Countries Growth Comparison
  • Figure 197: GCC Countries Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 198: GCC Countries Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 199: GCC Countries Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 200: Turkey Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 201: Global Vs. Turkey Growth Comparison
  • Figure 202: Turkey Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 203: Turkey Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 204: Turkey Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 205: South Africa Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 206: Global Vs. South Africa Growth Comparison
  • Figure 207: South Africa Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 208: South Africa Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 209: South Africa Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 210: North Africa Smart Inhalers Market Value Proportion Analysis, 2022
  • Figure 211: Global Vs North Africa Growth Comparison
  • Figure 212: North Africa Smart Inhalers Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 213: North Africa Smart Inhalers Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 214: North Africa Smart Inhalers Market Share Analysis (%) by Distribution Channel, 2022 & 2033
目次
Product Code: PMRREP26881

Smart Inhalers Market: Scope of Report

The latest publication by Persistence Market Research on the smart inhalers market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for the smart inhalers and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the smart inhalers market. Shareholders in the smart inhalers market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the smart inhalers market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the smart inhalers market offers information divided into four important segments - product, disease indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Dry Powder Inhaler (DPI)- based Smart Inhalers

Metered Dose Inhaler (MDI)- based Smart Inhalers

Disease Indication

Asthma

COPD

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for smart inhalers over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the smart inhalers market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the smart inhalers market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the smart inhalers market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Innovation / Development Trends

4. Key Success Factors

  • 4.1. Technological Advancements Regulatory Scenario
  • 4.2. Key Promotional Strategies, By Manufacturers
  • 4.3. Disease Epidemiology - COPD and Asthma
  • 4.4. New Product Approvals
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Outlook
    • 5.1.3. Respiratory Inhalers Market Analysis
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Lack of Awareness Regarding Symptoms of Asthma & COPD
    • 5.2.3. New Product Launches
    • 5.2.4. Growing Geriatric Population
    • 5.2.5. Increasing Prevalence of Asthma
    • 5.2.6. Product Adoption Rate
    • 5.2.7. Increased Funding and Support from the Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2022 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product
    • 6.2.2. By Disease Indication
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Region

7. Global Smart Inhalers Market Demand (in Volume) Analysis 2013-2022 and Forecast, 2023-2033

  • 7.1. Historical Market (Volume) Analysis, 2013-2022
  • 7.2. Current and Future Market (Volume) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Smart Inhalers Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis, By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer-Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Smart Inhalers Market Demand (in Value or Size in US$ Mn) Analysis 2013-2022 and Forecast, 2023-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2013-2022
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2013-2022
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2022-2032
    • 10.3.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
    • 10.3.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
  • 10.4. Market Attractiveness Analysis, By Product

11. Global Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033, By Disease Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis Technology, 2013-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2023-2033
    • 11.3.1. Asthma
    • 11.3.2. COPD
  • 11.4. Market Attractiveness Analysis, By End User

12. Global Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033, By Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis Application, 2013-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2033
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Market Attractiveness Analysis, By Distribution Channel

13. Global Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2013-2022
  • 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2022-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa
  • 13.4. Market Attractiveness Analysis, By Region

14. North America Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Disease Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Disease Indication
    • 14.4.4. By Distribution Channel
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Market Trends
  • 14.8. Country-Level Analysis & Forecast
    • 14.8.1. U.S. Smart Inhalers Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Disease Indication
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Canada Smart Inhalers Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Disease Indication
        • 14.8.2.2.3. By Distribution Channel

15. Latin America Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Argentina
      • 15.3.1.3. Mexico
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Disease Indication
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Disease Indication
    • 15.4.4. By Distribution Channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Market Trends
  • 15.8. Country-Level Analysis & Forecast
    • 15.8.1. Brazil Smart Inhalers Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Disease Indication
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Argentina Surgical Imaging Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Disease Indication
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. Mexico Smart Inhalers Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast, By Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Disease Indication
        • 15.8.3.2.3. By Distribution Channel

16. Europe Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Disease Indication
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Disease Indication
    • 16.4.4. By Distribution Channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Market Trends
  • 16.8. Country-Level Analysis & Forecast
    • 16.8.1. Germany Smart Inhalers Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Disease Indication
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. France Smart Inhalers Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Disease Indication
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. Italy Smart Inhalers Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Disease Indication
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. Spain Smart Inhalers Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Disease Indication
        • 16.8.4.2.3. By Distribution Channel
    • 16.8.5. U.K. Smart Inhalers Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Disease Indication
        • 16.8.5.2.3. By Distribution Channel
    • 16.8.6. BENULUX Smart Inhalers Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Disease Indication
        • 16.8.6.2.3. By Distribution Channel
    • 16.8.7. Russia Smart Inhalers Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast, By Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Disease Indication
        • 16.8.7.2.3. By Distribution Channel

17. South Asia Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Disease Indication
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Disease Indication
    • 17.4.4. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Market Trends
  • 17.8. Country-Level Analysis & Forecast
    • 17.8.1. India Smart Inhalers Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Disease Indication
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. Indonesia Smart Inhalers Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Disease Indication
        • 17.8.2.2.3. By Distribution Channel
    • 17.8.3. Malaysia Smart Inhalers Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast, By Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Disease Indication
        • 17.8.3.2.3. By Distribution Channel
    • 17.8.4. Thailand Smart Inhalers Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast, By Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Disease Indication
        • 17.8.4.2.3. By Distribution Channel

18. East Asia Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Disease Indication
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Disease Indication
    • 18.4.4. By Distribution Channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Market Trends
  • 18.8. Country-Level Analysis & Forecast
    • 18.8.1. China Smart Inhalers Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Disease Indication
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Japan Smart Inhalers Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Disease Indication
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. South Korea Smart Inhalers Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast, By Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Disease Indication
        • 18.8.3.2.3. By Distribution Channel

19. Oceania Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Disease Indication
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Disease Indication
    • 19.4.4. By Distribution Channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Market Trends
  • 19.8. Country-Level Analysis & Forecast
    • 19.8.1. Australia Smart Inhalers Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Disease Indication
        • 19.8.1.2.3. By Distribution Channel
    • 19.8.2. New Zealand Smart Inhalers Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Disease Indication
        • 19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Smart Inhalers Market Analysis 2013-2022 and Forecast 2023-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2013-2022
  • 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Disease Indication
    • 20.3.4. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Disease Indication
    • 20.4.4. By Distribution Channel
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Market Trends
  • 20.8. Country-Level Analysis & Forecast
    • 20.8.1. GCC Countries Smart Inhalers Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast, By Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Disease Indication
        • 20.8.1.2.3. By Distribution Channel
    • 20.8.2. Turkey Smart Inhalers Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast, By Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Disease Indication
        • 20.8.2.2.3. By Distribution Channel
    • 20.8.3. South Africa Smart Inhalers Market
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast, By Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Disease Indication
        • 20.8.3.2.3. By Distribution Channel
    • 20.8.4. North Africa Smart Inhalers Market
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast, By Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Disease Indication
        • 20.8.4.2.3. By Distribution Channel

21. Market Structure Analysis

  • 21.1. Market Analysis, By Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis
    • 21.3.1. Regional footprint of Players
    • 21.3.2. Platform Type foot print by Players
    • 21.3.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. OPKO Health, Inc
      • 22.3.1.1. Market Analysis by Tier of Companies
      • 22.3.1.2. Market Share Analysis of Top Players
      • 22.3.1.3. Market Presence Analysis
      • 22.3.1.4. Competition Dashboard
      • 22.3.1.5. Competition Deep Dive
      • 22.3.1.6. Strategy Analysis
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. AstraZeneca plc
      • 22.3.2.1. Market Analysis by Tier of Companies
      • 22.3.2.2. Market Share Analysis of Top Players
      • 22.3.2.3. Market Presence Analysis
      • 22.3.2.4. Competition Dashboard
      • 22.3.2.5. Competition Deep Dive
      • 22.3.2.6. Strategy Analysis
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. GlaxoSmithKline Plc.
      • 22.3.3.1. Market Analysis by Tier of Companies
      • 22.3.3.2. Market Share Analysis of Top Players
      • 22.3.3.3. Market Presence Analysis
      • 22.3.3.4. Competition Dashboard
      • 22.3.3.5. Competition Deep Dive
      • 22.3.3.6. Strategy Analysis
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Propeller Health
      • 22.3.4.1. Market Analysis by Tier of Companies
      • 22.3.4.2. Market Share Analysis of Top Players
      • 22.3.4.3. Market Presence Analysis
      • 22.3.4.4. Competition Dashboard
      • 22.3.4.5. Competition Deep Dive
      • 22.3.4.6. Strategy Analysis
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. Aptar Pharma
      • 22.3.5.1. Market Analysis by Tier of Companies
      • 22.3.5.2. Market Share Analysis of Top Players
      • 22.3.5.3. Market Presence Analysis
      • 22.3.5.4. Competition Dashboard
      • 22.3.5.5. Competition Deep Dive
      • 22.3.5.6. Strategy Analysis
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Adherium Limited
      • 22.3.6.1. Market Analysis by Tier of Companies
      • 22.3.6.2. Market Share Analysis of Top Players
      • 22.3.6.3. Market Presence Analysis
      • 22.3.6.4. Competition Dashboard
      • 22.3.6.5. Competition Deep Dive
      • 22.3.6.6. Strategy Analysis
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Novartis AG
      • 22.3.7.1. Market Analysis by Tier of Companies
      • 22.3.7.2. Market Share Analysis of Top Players
      • 22.3.7.3. Market Presence Analysis
      • 22.3.7.4. Competition Dashboard
      • 22.3.7.5. Competition Deep Dive
      • 22.3.7.6. Strategy Analysis
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. Boehringer Ingelheim
      • 22.3.8.1. Market Analysis by Tier of Companies
      • 22.3.8.2. Market Share Analysis of Top Players
      • 22.3.8.3. Market Presence Analysis
      • 22.3.8.4. Competition Dashboard
      • 22.3.8.5. Competition Deep Dive
      • 22.3.8.6. Strategy Analysis
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Teva Pharmaceutical Industries Ltd
      • 22.3.9.1. Market Analysis by Tier of Companies
      • 22.3.9.2. Market Share Analysis of Top Players
      • 22.3.9.3. Market Presence Analysis
      • 22.3.9.4. Competition Dashboard
      • 22.3.9.5. Competition Deep Dive
      • 22.3.9.6. Strategy Analysis
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. H&T Presspart Manufacturing Ltd.
      • 22.3.10.1. Market Analysis by Tier of Companies
      • 22.3.10.2. Market Share Analysis of Top Players
      • 22.3.10.3. Market Presence Analysis
      • 22.3.10.4. Competition Dashboard
      • 22.3.10.5. Competition Deep Dive
      • 22.3.10.6. Strategy Analysis
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Sensirion AG
      • 22.3.11.1. Market Analysis by Tier of Companies
      • 22.3.11.2. Market Share Analysis of Top Players
      • 22.3.11.3. Market Presence Analysis
      • 22.3.11.4. Competition Dashboard
      • 22.3.11.5. Competition Deep Dive
      • 22.3.11.6. Strategy Analysis
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. Cohero Health, Inc.
      • 22.3.12.1. Market Analysis by Tier of Companies
      • 22.3.12.2. Market Share Analysis of Top Players
      • 22.3.12.3. Market Presence Analysis
      • 22.3.12.4. Competition Dashboard
      • 22.3.12.5. Competition Deep Dive
      • 22.3.12.6. Strategy Analysis
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. RYAH Medtech Inc.
      • 22.3.13.1. Market Analysis by Tier of Companies
      • 22.3.13.2. Market Share Analysis of Top Players
      • 22.3.13.3. Market Presence Analysis
      • 22.3.13.4. Competition Dashboard
      • 22.3.13.5. Competition Deep Dive
      • 22.3.13.6. Strategy Analysis
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology